GlaxoSmithKline (GSK) and Community Care of North Carolina (CCNC) today announced a new approach to analyzing health information that allows healthcare providers and payers to improve health care quality and rein in cost.
Counter to healthcare trends focused on “big data,” this pilot’s “small data” approach focuses on select information, such as a patient’s prescription fill history and hospital admission and discharge data, that is widely available throughout the healthcare system and can predict when a patient is at risk of a negative health outcome.
These “prescriptive analytics” analyze the data and determine suggested interventions that are most likely to facilitate better patient engagement and ultimately, improved patient outcomes. The goal of the project is to assist healthcare professionals in determining – and responding to – medication-related problems that often lead patients to stray from the treatment regimen prescribed by their doctor
The complete media release is available here.
Media coverage: